AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
Amphastar executives will discuss future financial performance, business trends, and product strategies including BAQSIMI in an analyst-moderated presentation.
- On November 24, 2025 Amphastar Pharmaceuticals announced that Bill Peters and Tony Marrs will participate in a 7:30 a.m. fireside chat, with an archived edition available later that day.
- Using forward-looking phrasing, the release flags forward-looking statements with words like 'may' and 'expect' to outline Amphastar Pharmaceuticals, Inc.'s expectations on financial performance, FDA timing, product launches and market expansion.
- Amphastar specifically cautioned about BAQSIMI sales, warning there is no guarantee of continued significant sales and actual results may differ materially due to known and unknown risks.
- A live audio webcast will be available through AbbVie's Investor Relations website, with an archived edition posted later that day; investors were directed to Amphastar's SEC filings and IR site for details.
- Because the statements are time‑bound, Amphastar says forward-looking statements speak only as of the release date and undertakes no obligation to update them.
14 Articles
14 Articles
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
NEW HAVEN, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 2:35 p.m. ET in…
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
VALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that the Company will present at the Piper Sandler 37th Annual Healthcare Conference…
ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating…
Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted...
AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference
NORTH CHICAGO, Ill., Nov. 24, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.
AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference
NORTH CHICAGO, Ill., Nov. 24, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium











